MedTrace Logo

Efficacy of Yogurt Containing BB12 in Subjects With GI Symptoms

NCT00618488 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2008-02-20

No results posted yet for this study

Summary

The purpose of this study is to determine if probiotics bacteria, specifically bifidobacterium lactis (BB12) improve gastrointestinal symptoms in subjects with functional gastrointestinal symptoms (i.e., non-patients IBS/functional bowel disorders).

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic BB12 - Bifidobacterium lactis

Bifidobacterium lactis (3.1 oz yogurt) administered once a day for 6 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo administered once a day for 6 weeks

Sponsors & Collaborators

  • General Mills

    collaborator INDUSTRY

  • University of North Carolina

    lead OTHER

Principal Investigators

  • Yehuda Ringel, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00618488 on ClinicalTrials.gov